AptaBio Therapeutics Inc. (KOSDAQ:293780)
7,000.00
+280.00 (4.17%)
Apr 10, 2026, 3:30 PM KST
2.34% (1Y)
| Market Cap | 196.65B -1.9% |
| Revenue (ttm) | 3.70B +10.0% |
| Net Income | -16.35B |
| EPS | -607.00 |
| Shares Out | 28.09M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 58,363 |
| Average Volume | 102,622 |
| Open | 6,740.00 |
| Previous Close | 6,720.00 |
| Day's Range | 6,740.00 - 7,050.00 |
| 52-Week Range | 6,060.00 - 11,960.00 |
| Beta | 0.92 |
| RSI | 47.80 |
| Earnings Date | May 14, 2026 |